DiseaseInfo Viewer : HIX0022762
| Transcripts | HIT000025533 HIT000036509 HIT000038416 HIT000041270 HIT000268311 HIT000279243 HIT000300418 |
|---|---|
| UCSC Genome browser | chr8:145159305-145162515 |
| G-integra | chr8:145159305-145162515 |
| Map position | 8q24.3 |
| Symbol | MAF1 |
| OMIM | NA |
| Disease name | NA |
| MutationView | - |
Orphan diseases co-localized with HIX0022762
The number of co-localized H-Inv loci was computed by converting each cytogenetic band into a physical range on the chromosome, with additional 1000000 bp added on each side.
| Symbol | OMIM phenotype | Entrez Gene | GenAtlas |
Cytogenetic band (Link to the latest human genome on UCSC Genome Browser) |
Number-of co-localized H-Inv loci (Click for list) | Description | Source | |
|---|---|---|---|---|---|---|---|---|
| 1 | BMND10 | 612113 | 100188883 | - | 8q24 | 464 | Bone mineral density QTL 10 | OMIM |
| 2 | BSZQTL3 | 610649 | 100188815 | - | 8q24 | 464 | Bone size quantitative trait locus 3 | OMIM |
| 3 | CRCS2 | 611469 | 100188841 | - | 8q24 | 464 | Colorectal cancer, susceptibility to, 2 | OMIM |
| 4 | ECA1 | 600131 | 50966 | 27525 | 8q24 | 464 | epilepsy, childhood absence 1 | OMIM |
| 5 | FCMTE1 | 601068 | 50968 | 35086 | 8q24 | 464 | familial cortical myoclonic tremor with epilepsy 1 | OMIM |
| 6 | HPC10 | 611100 | 100188834 | - | 8q24 | 464 | Prostate cancer, hereditary, 10 | OMIM |
| 7 | HPV18I1 | 167959 | 3260 | - | 8q24 | 464 | human papilloma virus (type 18) integration site 1 | OMIM |
| 8 | HT | 140300 | 140805 | 33723 | 8q23-q24 | 510 | Hashimoto thyroiditis | OMIM |
| 9 | HT | 140300 | 140805 | 33724 | 8q23-q24 | 510 | Hashimoto thyroiditis | OMIM |
| 10 | MGS | 611376 | 100126595 | - | 8q23-q24 | 510 | Mungen syndrome | OMIM |
| 11 | CCAL1 | 600668 | 882 | 18973 | 8q | 1063 | chondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) | OMIM |
| 12 | FHQTL | 606789 | 171515 | - | 8q | 1063 | Fetal hemoglobin QTL on chromosome 8 | OMIM |
This database and viewer were originally developed by Dr. Boris Lenhard at Karolinska Institute.
$Revision: 1.58.2.9.2.46 $



